title: Interference of New Drugs with Compatibility Testing for Blood Transfusion.
authors.affiliation: John Radcliffe Hospital, Oxford, United Kingdom mike.murphy@nbs.nhs.uk.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Murphy
authors.affiliation: Geisel School of Medicine at Dartmouth, Lebanon, NH.
authors.forename: Larry J
authors.initials: LJ
authors.lastname: Dumont
authors.affiliation: Universitätsmedizin Greifswald, Greifswald, Germany.
authors.forename: Andreas
authors.initials: A
authors.lastname: Greinacher
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000378:metabolism; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001771:Blood Banks; D001788:Blood Grouping and Crossmatching; D001803:Blood Transfusion; D003429:Cross Reactions / Q000187:drug effects; D005189:False Positive Reactions; D006801:Humans; D016756:Immunoglobulins, Intravenous
chemical_list: D000911:Antibodies, Monoclonal; D016756:Immunoglobulins, Intravenous; C556306:daratumumab; D051997:ADP-ribosyl Cyclase 1